{
  "trial_id": "NCT02113332",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "population will be identified among diabetic outpatient clinics at hospitals and will be recruited on a community-wide basis and in communication with primary care physicians.",
      "label": "met"
    },
    {
      "criterion": "The written information will include objects and purpose of the study, risks and benefits, and a detailed description of the events during the study. The patient will have the opportunity to ask additional questions at the first clinic visit",
      "label": "met"
    },
    {
      "criterion": "patients will be randomised 1:1 to liraglutide or placebo Randomisation codes will be assigned strictly sequentially as subjects are eligible for randomisation.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Type 1 diabetes",
      "label": "triggers"
    },
    {
      "criterion": "Fasting glucose less than 6.0 mmol/l or greater than 15.0 mmol/l",
      "label": "triggers"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "29",
    "trial_id": "NCT02113332",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}